Medios: robust Q3 driven by margin expansion with Ceban integration on track
Medios delivered a standout Q3 2024, achieving its highest quarterly performance to date. 9M 2024 revenue increased by 4.2% YoY to EUR1.40bn, in line with our estimate of EUR1.39bn, driven by positive momentum in Q3 across all segments. Notably, i) Pharmaceutical Supply (PS) saw a 4% QoQ rebound afMedios AG. Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.